 Nematode vaccines marketed to date have been of the irradiated larval type and used exclusively for the treatment of animals.These vaccines are not stable and require annual production, involving the yearly production and sacrifice of donor animals for passage.There has been much interest in the production of subunit vaccines against human and agricultural parasites since the early 1980s.